Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR4 | O95977 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.46 |
| ▸ | HPGD | P15428 | 5/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.46 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 5/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.42 |
| ▸ | NPC1 | O15118 | 4/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.42 |
| ▸ | RELA | Q04206 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL499141 | 0.84 | ALDH1A1 (0.53) | S1PR4ALDH1A1KDM4EHPGDMAPT | |
| SCHEMBL22945653 | 0.76 | ALDH1A1 (0.44) | S1PR4ALDH1A1KDM4EHPGDMAPT | |
| SCHEMBL3349294 | 0.76 | ALDH1A1 (0.38) | S1PR4ALDH1A1KDM4EHPGDMAPT | |
| SCHEMBL18876413 | 0.75 | ALDH1A1 (0.46) | S1PR4ALDH1A1KDM4EHPGDMAPT | |
| SCHEMBL17269675 | 0.75 | PDE10A (0.40) | ALDH1A1KDM4EHPGDMAPTTDP1 | |
| SCHEMBL18879678 | 0.75 | KDM4E (0.46) | S1PR4ALDH1A1KDM4EHPGDMAPT | |
| SCHEMBL10287183 | 0.75 | KDM4E (0.58) | S1PR4ALDH1A1KDM4EHPGDMAPT | |
| SCHEMBL10253758 | 0.75 | ALDH1A1 (0.43) | S1PR4ALDH1A1KDM4EHPGDMAPT | |
| SCHEMBL28879176 | 0.73 | ALDH1A1 (0.49) | S1PR4ALDH1A1KDM4EHPGDMAPT | |
| SCHEMBL14854115 | 0.73 | TDP1 (0.48) | S1PR4ALDH1A1KDM4EHPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11289654-B2 | Polymers containing furanyl crosslinkable groups and uses thereof | GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) | 2022-03-29 | — | — | US | disclosed |
| US-11193065-B2 | Liquid crystal composition, method of producing the same, and retardation film constituted from the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-12-07 | — | — | US | disclosed |
| US-20200165519-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION AND RETARDATION PLATE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-05-28 | — | — | US | disclosed |
| EP-3560917-A1 | POLYMER CONTAINING FURAN CROSSLINKING GROUP AND USE THEREOF | Guangzhou Chinaray Optoelectronic Materials Ltd. (CN) | 2019-10-30 | — | — | EP | disclosed |
| US-20190276744-A1 | LIQUID CRYSTAL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-09-12 | — | — | US | disclosed |
| US-10407619-B2 | Liquid crystal composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-09-10 | — | — | US | disclosed |
| US-10336938-B2 | Liquid crystal composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-07-02 | — | — | US | disclosed |
| WO-2019053540-A1 | METHODS OF PRODUCING ALPHA, BETA-UNSATURATED CARBOXYLIC ACID SALTS FROM ALKANES AND CARBON DIOXIDE | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2019-03-21 | — | — | WO | disclosed |
| WO-2019053541-A1 | ACRYLATES THROUGH OLEFIN/CARBON DIOXIDE COUPLING | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2019-03-21 | — | — | WO | disclosed |
| US-20190077762-A1 | QUINOLONE COMPOUND | OTSUKA PHARMA CO LTD (JP) | 2019-03-14 | — | — | US | disclosed |
| US-20140302637-A1 | POLYMERS BASED ON BENZODIONES | BASF SE (DE) | 2014-10-09 | — | — | US | disclosed |
| US-8835644-B2 | Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2014-09-16 | — | — | US | disclosed |
| WO-2014072292-A2 | POLYMERS BASED ON NAPHTHODIONES | BASF SE (DE) | 2014-05-15 | — | — | WO | disclosed |
| WO-2014016219-A1 | DITHIENOBENZOFURAN POLYMERS AND SMALL MOLECULES FOR ELECTRONIC APPLICATION | BASF SE (DE) | 2014-01-30 | — | — | WO | disclosed |
| WO-2013150005-A1 | DIKETOPYRROLOPYRROLE POLYMERS AND SMALL MOLECULES | BASF SE (DE) | 2013-10-10 | — | — | WO | disclosed |
| WO-2013149897-A1 | PHENANTHRO[9,10-B]FURAN POLYMERS AND SMALL MOLECULES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2013-10-10 | — | — | WO | disclosed |
| WO-2013050401-A2 | POLYMERS BASED ON BENZODIONES | BASF SE (DE) | 2013-04-11 | — | — | WO | disclosed |
| WO-2010045009-A1 | PHENYL AND HETEROARYL SUBSTITUTED THIENO[2,3-d] PYRIMIDINES AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS | JANSSEN PHARMACEUTICA NV (BE) | 2010-04-22 | — | — | WO | disclosed |
| WO-2010045016-A1 | HETEROCYCLYL AND CYCLOALKYL SUBSTITUTED THIENO [2,3-D] PYRIMIDINE AND THEIR USE AS ADENOSINE A2A RECEPTOR ANTAGONISTS | JANSSEN PHARMACEUTICA NV (BE) | 2010-04-22 | — | — | WO | disclosed |
| WO-2010045015-A1 | HETEROARYL SUBSTITUTED THIENO[2,3-D]PYRIMIDINE AND THEIR USE AS ADENOSINE A2A RECEPTOR ANTAGONISTS | JANSSEN PHARMACEUTICA NV (BE) | 2010-04-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190077762-A1 | QUINOLONE COMPOUND | HAX1, NQO2, NHERF1 | S1PR4 4220/4885ALDH1A1 1466/4885KDM4E 3068/4885 |
| US-10407619-B2 | Liquid crystal composition | RCC1, CCDC47, ACIN1 | S1PR4 4499/4885ALDH1A1 4362/4885KDM4E 2427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.